Review—Recent Advances Based on a Sensor for Cancer Biomarker Detection
Source abstract
Abstract
Cancer is a worldwide disease with a high mortality rate and traditional methods for the diagnosis and monitoring are performed through invasive techniques. Currently, the advance of research in medical and biomedical engineering allowed the use of molecular tools combined with nanotechnology to develop portable sensors specific for major biomarkers to diagnose, monitor, and treatment of several diseases. This sensor can offer a means of homogeneous classification of a disease and risk factor and can extend the basic information about the underlying pathogenesis of the disease. Therefore, they can play a critical role in all stages of the disease. To address all this requirement is important to have a rigorous evaluation, including analytical validation, before incorporated into routine clinical treatment. This review described the current stage in the development of sensors in the study of cancer with an emphasis on surface modification, immobilization of biological agents, and detection approach.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (98)
Show source-provided references
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 201210.1002/ijc.29210 ↗
2. Biomarkers in cancer screening, research and detection: present and future: a review10.1080/13547500600775011 ↗
3. Cancer biomarkes10.1016/j.molonc.2012.01.010 ↗
4. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework10.1067/mcp.2001.113989 ↗
5. Biomarkers: potential uses and limitations10.1602/neurorx.1.2.182 ↗
6. Novel diagnostic biomarkers for prostate cancer10.7150/jca.1.150 ↗
7. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review10.1093/jnci/djs207 ↗
8. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?10.1186/1741-7015-10-87 ↗
9. Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer10.1371/journal.pone.0133830 ↗
10. CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases10.1016/S0959-8049(00)00396-8 ↗
11. HER2-positive breast cancer10.1016/S0140-6736(16)32417-5 ↗
12. Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in gastrointestinal cancer using LOCI™-based assays10.21873/anticanres.11329 ↗
13. Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer10.1111/jgh.13653 ↗
14. Demonstration of gamma-glutamyl transferase, alkaline phosphatase, CEA and HCG in human lung cancer
15. Potential markers that complement expression of CA125 in epithelial ovarian cancer10.1016/j.ygyno.2005.06.040 ↗
16. Dual-label immunoassay for simultaneous measurement of prostate-specific antigen (PSA)-alpha1-antichymotrypsin complex together with free or total PSA10.1373/49.1.97 ↗
17. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature10.1159/000217755 ↗
18. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma10.1007/s13277-013-0966-x ↗
19. Pancreatic oncofoetal antigen (POA): its frequency and localisation in humans
20. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy10.1200/JCO.2009.21.9170 ↗
21. ERCC1 and TS expression as prognostic and predictive biomarkers in metastatic Colon cancer10.1371/journal.pone.0126898 ↗
22. Biomarkers of angiogenesis and their role in the development of VEGF inhibitors10.1038/sj.bjc.6605483 ↗
23. Measurement of biomarkerproteins for point-of-care early detection and monitoring of cancer10.1039/c0an00204f ↗
24. Electrochemical biosensing to move forward in cancer epigenetics and metastasis: A review10.1016/j.aca.2020.01.047 ↗
25. Integration of a bio-chip technique with technetium-99m labeling provides zeptomolar sensitivity in liver cancer biomarker detection10.1039/C4AY02783C ↗
26. Novel signal-enhancing immunoassay for ultrasensitive biomarker detection based on laser-induced fluorescence10.1021/ac504515g ↗
27. Complementary glycomic analyses of sera derived from colorectal cancer patients by MALDI-TOF-MS and microchip electrophoresis10.1021/acs.analchem.6b02310 ↗
28. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations10.1016/j.talanta.2016.04.049 ↗
29. Microfluidics--downsizing large-scale biology10.1038/90754 ↗
30. Adaptation of a surface plasmon resonance biosensor with microfluidics for use with small sample volumes and long contact times10.1021/ac0100042 ↗
31. Parallel nanoliter detection of cancer markers using polymer microchips10.1039/B415525D ↗
32. Bioassay of prostate-specific antigen (PSA) using microcantilevers10.1038/nbt0901-856 ↗
33. Translating biomolecular recognition into nanomechanics10.1126/science.288.5464.316 ↗
34. , ‘Nanotechnologies for biomolecular detection and medical diagnostics10.1016/j.cbpa.2006.01.006 ↗
35. Biomarkers in cancer staging, prognosis and treatment selection10.1038/nrc1739 ↗
36. Affinity and enzyme-based biosensors: recent advances and emerging applications in cell analysis and point-of-care testing10.1007/s00216-012-6149-6 ↗
37. A review on carbon nanotubes in biosensor devices and their applications in medicine10.1080/20550324.2018.1478765 ↗
38. Carbon‐nanotube based electrochemical biosensors: a review10.1002/elan.200403113 ↗
39. Recent trends in carbon nanomaterial-based electrochemical sensors for biomolecules: a review10.1016/j.aca.2015.05.049 ↗
40. Highly sensitive impedimetric immunosensor for determination of interleukin 6 as a cancer biomarker by using conjugated polymer containing epoxy side groups modified disposable ITO electrode10.1016/j.talanta.2020.120909 ↗
41. Design of organic/inorganic nanocomposites for ultrasensitive electrochemical detection of a cancer biomarker protein10.1016/j.talanta.2020.120794 ↗
42. A novel electrochemical immunosensor for ultrasensitive detection of CA125 in ovarian cancer10.1016/j.bios.2020.112029 ↗
43. Detection of the prostate cancer biomarker PCA3 with electrochemical and impedance-based biosensors10.1021/acsami.9b19180 ↗
44. Nanostructured materials with plasmonic nanobiosensors for early cancer detection: a past and future prospect10.1016/j.bios.2017.08.044 ↗
45. Biomolecule-nanoparticle hybrid systems for bioelectronics applications10.1016/j.bioelechem.2006.03.013 ↗
46. Cancer biomarker detection in human serum samples using nanoparticle decorated epitope-mediated hybrid MIP10.1016/j.bios.2020.112464 ↗
47. Highly sensitive and selective photoelectrochemical aptasensor for cancer biomarker CA125 based on AuNPs/GaN schottky junction10.1021/acs.analchem.0c02117 ↗
48. Antibodies and antibody-derived analytical biosensors10.1042/EBC20150002 ↗
49. Vashist · 2018 · 496
50. Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD10.1016/j.talanta.2014.06.035 ↗
51. An electrochemical immunosensor based on enzyme-encapsulated liposomes and biocatalytic metal deposition10.1016/j.aca.2010.01.050 ↗
52. Novel electrochemical immune sensor based on Hep-PGA-PPy nanoparticles fordetection of α-Fetoprotein in whole blood10.1016/j.aca.2017.04.045 ↗
53. Conductive hydrogel composed of 1,3,5-benzenetricarboxylic acid and Fe3 + used as enhanced electrochemical immunosensing substrate for tumor biomarker10.1016/j.bioelechem.2016.12.006 ↗
54. Gold nanorods-paper electrode based enzyme-free electrochemical immunoassay of prostate specific antigen using porous zinc oxide spheres-silver nanoparticles nanocomposites as labels10.1039/C5NJ00629E ↗
55. Ultrasensitive electrochemical immunosensor for carbohydrate antigen 72-4 based on dual signal amplification strategy of nanoporous gold and polyaniline–Au asymmetric multicomponent nanoparticles10.1016/j.bios.2014.08.043 ↗
56. 3D-printed immunosensor arrays for cancer diagnostics10.3390/s20164514 ↗
57. 3D-printed supercapacitor-powered electrochemiluminescent protein immunoarray10.1016/j.bios.2015.09.017 ↗
58. A sensitive electrochemiluminescence immunosensor based on luminophore capped Pd@Au core-shell nanoparticles as signal tracers and ferrocenyl compounds as signal enhancers10.1016/j.bios.2016.03.014 ↗
59. An ultrasensitive electrochemiluminescence immunosensor based on platinum nickel nanocubes-L-cysteine-luminol nanocomposite10.1016/j.talanta.2018.04.069 ↗
60. Dual-responsive immunosensor that combines colorimetric recognition and electrochemical response for ultrasensitive detectionof cancer biomarkers10.1016/j.bios.2016.07.014 ↗
61. Suppressing non-specific binding of proteins onto electrode surfaces in the development of electrochemical immunosensors10.3390/bios9010015 ↗
62. IgY: a promising antibody for use in immunodiagnostic and in immunotherapy10.1016/j.vetimm.2009.12.011 ↗
63. Immunoglobulins of the chicken
64. Recent advances in immobilization methods of antibodies on solid supports10.1039/b800014j ↗
65. Detection of CD133-marked cancer stem cells by surface plasmon resonance: its application in leukemia patients10.1016/j.bbagen.2019.06.009 ↗
66. Fluorescence immunoassay based on nitrogen doped carbon dots for the detection of human nuclear matrix protein NMP22 as biomarker for early stage diagnosis of bladder câncer10.1016/j.microc.2020.104966 ↗
67. Electrochemical biosensing in cancer diagnostics and follow-up10.1002/elan.201800193 ↗
68. Graphene nanosheets as an electric mediator for ultrafast sensing ofurokinase plasminogen activator receptor-A biomarker of câncer10.1016/j.bios.2019.111398 ↗
69. Polyaniline based electrochemical biosensor for α‐fetoprotein detection using bio‐functionalized nanoparticles as detection probe10.1002/elan.202060219 ↗
70. Horseradish peroxidase-loaded nanospheres attached to hollow gold nanoparticles as signal enhancers in an ultrasensitive immunoassay for alpha-fetoprotein10.1007/s00604-014-1179-8 ↗
71. Metal and metal oxide nanoparticles to enhance the performance of enzyme-linked immunosorbent assay (ELISA)10.1021/acsanm.9b02003 ↗
72. Hnasko · 2015 · 216
73. Electrochemical biosensors for determination of colorectal tumor biomarkers10.3390/mi11040411 ↗
74. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye10.1038/nnano.2012.186 ↗
75. Manganese dioxide nanoparticle-based colorimetric immunoassay for the detection of alpha-fetoprotein10.1007/s00604-017-2303-3 ↗
76. Pd–Ir core–shell nanocubes: a type of highly efficient and versatile peroxidase mimic10.1021/acsnano.5b03525 ↗
77. Recent advances in DNA Biosensor.’
78. Electrochemical DNA biosensor for detecting cancer biomarker related to glutathione S-transferase P1 (GSTP1) hypermethylation in real samples10.1016/j.bios.2011.11.029 ↗
79. advances on the DNA-based electrochemical biosensing ofcancer biomarkers: analytical approach10.1016/j.trac.2019.07.020 ↗
80. Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA10.1016/j.bios.2016.04.035 ↗
81. Ultra-sensitive DNA sensor based on AuNPs/RGO/GCE10.1016/j.ab.2015.05.009 ↗
82. Bio/Abiotic interface constructed from nanoscale dna dendrimer and conducting polymer for ultrasensitive biomolecular diagnosis10.1002/smll.200900369 ↗
83. Ultrasensitive immunoassay of protein biomarker based on electrochemiluminescent quenching of quantum dotsby hemin bio-bar-coded nanoparticle tags10.1021/ac200398x ↗
84. 3D DNA nanosphere-based photoelectrochemical biosensor combined with multiple enzyme-free amplification for ultrasensitive detection of cancer biomarkers10.1016/j.bios.2019.111778 ↗
85. Electrochemical biosensors—sensor principles and architectures10.3390/s80314000 ↗
86. A novel signal-amplified electrochemical aptasensor based on supersandwich G-quadruplex DNAzyme for highly sensitive cancer cell detection10.1016/j.elecom.2015.01.015 ↗
87. A label-free electrochemical impedance cytosensor based on specific peptide-fused phage selected from landscape phage library10.1038/srep22199 ↗
88. Ultrasensitive self-powered cytosensor10.1016/j.nanoen.2015.03.035 ↗
89. Effective cell capture with tetrapeptide-functionalized carbon nanotubes and dual signal amplification for cytosensing and evaluation of cell surface carbohydrate10.1021/ac800199t ↗
90. Electrochemical biosensors—sensor principles and architectures10.3390/s80314000 ↗
91. A novel signal-amplified electrochemical aptasensor based on supersandwich G-quadruplex DNAzyme for highly sensitive cancer cell detection10.1016/j.elecom.2015.01.015 ↗
92. Recent advances in nanostructures and nanocrystals as signal-amplification elements in electrochemical cytosensing.’10.1016/j.trac.2015.04.020 ↗
93. Nanomaterials in electrochemical cytosensors10.1039/C9AN01895F ↗
94. Electrochemical cytosensors for detection of breast cancer cells10.1016/j.bios.2019.111984 ↗
95. Electrical detection method for circulating tumor cells using graphene nanoplates10.1021/acs.analchem.5b03147 ↗
96. Hydrogen peroxide detection at a horseradish peroxidase biosensor with an Au nanoparticle–dotted titanate nanotube∣ hydrophobic ionic liquid scaffold10.1016/j.bios.2011.12.002 ↗
97. Genetically engineered pfabA pfabR bacteria: an electrochemical whole cell biosensor for detection of water toxicity10.1021/ac052096r ↗
98. A handheld device for potential point-of-care screening of cancer10.1039/b617733f ↗